FDA
-
-
-
-
-
-
-
Helix BioPharma Corp. Provides Strategic Update on L-DOS47 Clinical Program
-
-
-
-
-
-
-
Helix BioPharma Corp. announces FDA approval to Accelerate Dose Escalation for U.S. Phase I Clinical Study
-
322,967 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

